Du Yang Timothy, Roberts Anthony P, Torpy David J
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia.
Discipline of Medicine, The University of Adelaide, Adelaide, Australia.
BMJ Case Rep. 2017 May 3;2017:bcr-2016-219158. doi: 10.1136/bcr-2016-219158.
A middle-aged woman with diabetic nephropathy on pregabalin for neuropathic pain presented with a diarrhoeal illness. She was found to have acute on chronic renal impairment with an estimated glomerular filtration rate (eGFR) of 10 mL/min, and her usual 150 mg/day of pregabalin was abruptly ceased. Although renal recovery to her baseline of eGFR 15 mL/min was achieved within 3 days, her pregabalin was not restarted. She suffered a tonic-clonic seizure 4 days later, thought to be due to pregabalin withdrawal as there were no other likely causes identified. She suffered no further seizures on recommencement of pregabalin at a renally adjusted dose of 75 mg/day.
一名患有糖尿病肾病且正在服用普瑞巴林治疗神经性疼痛的中年女性出现腹泻疾病。她被发现存在急性慢性肾功能损害,估计肾小球滤过率(eGFR)为10毫升/分钟,她通常每天服用的150毫克普瑞巴林被突然停用。尽管在3天内肾功能恢复到了她的基线水平,即eGFR为15毫升/分钟,但她的普瑞巴林并未重新开始服用。4天后她发生了一次强直阵挛性发作,考虑是由于普瑞巴林撤药所致,因为未发现其他可能的原因。在以肾脏调整剂量每天75毫克重新开始服用普瑞巴林后,她未再发生癫痫发作。